Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blood Glucose Optimization and Prognostic Model in Traumatic Brain Injury Patients with Diabetes
ChiCTR2300071498Phase 4Not yet recruiting
- Sponsor
- Hengshui People's Hospital
- Start
- Nov 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of human insulin in traumatic brain injury (TBI) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Hengshui People's Hospital. Primary endpoints: Daily Living Activity Rating, Glasgow Coma Scale and 1 more. Planned start Nov 2021; status: not yet recruiting.
02
Drugs
human insulin
03
Conditions
traumatic brain injury (TBI)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2300071498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071498.